+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Antipsychotic Drugs Market Research Report by Class, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 252 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5305498
UP TO OFF until Dec 31st 2022
The Global Antipsychotic Drugs Market size was estimated at USD 8,308.75 million in 2021, USD 8,951.74 million in 2022, and is projected to grow at a CAGR of 7.91% to reach USD 13,123.38 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Antipsychotic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Class, the market was studied across First Generation, Second Generation, and Third generation. The First Generation is further studied across Haldo and Navane. The Second Generation is further studied across Geodon, Invega, Latuda, Risperdal, Seroquel, and Zyprexa. The Third generation is further studied across Abilify.
  • Based on Application, the market was studied across Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Antipsychotic Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antipsychotic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antipsychotic Drugs Market, including Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories, Ltd., Eli Lilly & Co., F.Hoffmann-La Roche AG, Flagship Biotech International Pvt. Ltd, GlaxoSmithKline PLC, H. Lundbeck A/S, Karger AG, Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Questex LLC, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., The Medicines Co., and Vanda Pharmaceuticals Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Antipsychotic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antipsychotic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antipsychotic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Antipsychotic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Antipsychotic Drugs Market?
6. What is the market share of the leading vendors in the Global Antipsychotic Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Antipsychotic Drugs Market?
Frequently Asked Questions about the Global Antipsychotic Drugs Market

What is the estimated value of the Global Antipsychotic Drugs Market?

The Global Antipsychotic Drugs Market was estimated to be valued at $8308.75 Million in 2021.

What is the growth rate of the Global Antipsychotic Drugs Market?

The growth rate of the Global Antipsychotic Drugs Market is 7.9%, with an estimated value of $13123.38 Million by 2027.

What is the forecasted size of the Global Antipsychotic Drugs Market?

The Global Antipsychotic Drugs Market is estimated to be worth $13123.38 Million by 2027.

Who are the key companies in the Global Antipsychotic Drugs Market?

Key companies in the Global Antipsychotic Drugs Market include Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol, Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories, Ltd. and F.Hoffmann.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of psychosis and associated diseases
5.1.2. Restraints
5.1.2.1. Patent expiry of established brands
5.1.3. Opportunities
5.1.3.1. Increasing prevalence of psychosis and associated diseases
5.1.3.2. Enhancement in healthcare facilities coupled with government efforts to improve healthcare sector
5.1.4. Challenges
5.1.4.1. Negative impact on the patients such as insomnia, blurred vision, and dry mouth
5.1.4.2. Stringent regulatory framework and compliance
5.2. Cumulative Impact of COVID-19
6. Antipsychotic Drugs Market, by Class
6.1. Introduction
6.2. First Generation
6.3.1. Haldo
6.3.2. Navane
6.3. Second Generation
6.4.1. Geodon
6.4.2. Invega
6.4.3. Latuda
6.4.4. Risperdal
6.4.5. Seroquel
6.4.6. Zyprexa
6.4. Third generation
6.5.1. Abilify
7. Antipsychotic Drugs Market, by Application
7.1. Introduction
7.2. Bipolar disorders
7.3. Dementia
7.4. Schizophrenia
7.5. Unipolar Depression
8. Americas Antipsychotic Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Antipsychotic Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Antipsychotic Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Alkermes PLC
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Allergan PLC
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. AMBOSS GmbH
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. AstraZeneca PLC
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Bristol-Myers Squibb Company
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Daiichi Sankyo Co. Ltd.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Dr. Reddy's Laboratories, Ltd.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Eli Lilly & Co.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. F.Hoffmann-La Roche AG
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Flagship Biotech International Pvt. Ltd
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. GlaxoSmithKline PLC
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. H. Lundbeck A/S
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Karger AG
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Luye Pharma Group
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Merck & Co., Inc.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Novartis AG
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Otsuka Pharmaceutical Co. Ltd.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Pfizer, Inc.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Questex LLC
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Sumitomo Dainippon Pharma Co., Ltd.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Teva Pharmaceutical Industries, Ltd.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. The Medicines Co.
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Vanda Pharmaceuticals Inc.
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET DYNAMICS
FIGURE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY CLASS, 2027
FIGURE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 27. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 29. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, 2018-2027 (USD MILLION)
FIGURE 33. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 35. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 36. AMERICAS ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 37. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 43. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 45. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 47. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 49. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 65. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 87. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 88. GLOBAL ANTIPSYCHOTIC DRUGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 58. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 59. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 60. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 61. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 62. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 63. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 64. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 65. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 66. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 67. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 68. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 69. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 70. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 71. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 74. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 75. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 80. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 82. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 83. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 85. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 88. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 89. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 91. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 92. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 94. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 95. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 97. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 98. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 99. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 100. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 101. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 102. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 103. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 104. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 106. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 107. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 109. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 110. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 111. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 112. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 113. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 114. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 115. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 120. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 122. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 123. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 125. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 126. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 128. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 129. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 131. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 132. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 134. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 135. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 137. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 138. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 140. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 141. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 143. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 144. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 146. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 147. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 149. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 150. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 151. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 152. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 153. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 154. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 155. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 156. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 158. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 159. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 160. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 161. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 162. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 163. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 164. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 165. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 166. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 167. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 168. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 170. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 171. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 172. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 173. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 174. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 175. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 176. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 180. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 182. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 183. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 184. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 185. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 186. GLOBAL ANTIPSYCHOTIC DRUGS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 187. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 188. GLOBAL ANTIPSYCHOTIC DRUGS MARKET MERGER & ACQUISITION
TABLE 189. GLOBAL ANTIPSYCHOTIC DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 190. GLOBAL ANTIPSYCHOTIC DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 191. GLOBAL ANTIPSYCHOTIC DRUGS MARKET INVESTMENT & FUNDING
TABLE 192. GLOBAL ANTIPSYCHOTIC DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 193. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • Alkermes PLC
  • Allergan PLC
  • AMBOSS GmbH
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Co. Ltd.
  • Dr. Reddy's Laboratories, Ltd.
  • Eli Lilly & Co.
  • F.Hoffmann-La Roche AG
  • Flagship Biotech International Pvt. Ltd
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Karger AG
  • Luye Pharma Group
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer, Inc.
  • Questex LLC
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • The Medicines Co.
  • Vanda Pharmaceuticals Inc.

Methodology

Loading
LOADING...